BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8158127)

  • 1. Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes.
    Pacheco MA; Ward SJ; Childers SR
    J Neurochem; 1994 May; 62(5):1773-82. PubMed ID: 8158127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cannabinoid receptors in cultures of rat cerebellar granule cells.
    Pacheco MA; Ward SJ; Childers SR
    Brain Res; 1993 Feb; 603(1):102-10. PubMed ID: 8384043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.
    Selley DE; Stark S; Sim LJ; Childers SR
    Life Sci; 1996; 59(8):659-68. PubMed ID: 8761016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
    Stark S; Pacheco MA; Childers SR
    Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.
    Sim LJ; Selley DE; Childers SR
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7242-6. PubMed ID: 7638174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain.
    Childers SR; Fleming L; Konkoy C; Marckel D; Pacheco M; Sexton T; Ward S
    Ann N Y Acad Sci; 1992 Jun; 654():33-51. PubMed ID: 1321574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes.
    Rhee MH; Bayewitch M; Avidor-Reiss T; Levy R; Vogel Z
    J Neurochem; 1998 Oct; 71(4):1525-34. PubMed ID: 9751186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of anandamide on cannabinoid receptors in rat brain membranes.
    Childers SR; Sexton T; Roy MB
    Biochem Pharmacol; 1994 Feb; 47(4):711-5. PubMed ID: 8129747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
    Nijssen PC; Sexton T; Childers SR
    J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum.
    Devlin MG; Christopoulos A
    J Neurochem; 2002 Mar; 80(6):1095-102. PubMed ID: 11953460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC; Lo SW; Hsu KS
    J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation.
    Selley DE; Rorrer WK; Breivogel CS; Zimmer AM; Zimmer A; Martin BR; Sim-Selley LJ
    J Neurochem; 2001 May; 77(4):1048-57. PubMed ID: 11359870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids modulate potassium current in cultured hippocampal neurons.
    Deadwyler SA; Hampson RE; Bennett BA; Edwards TA; Mu J; Pacheco MA; Ward SJ; Childers SR
    Recept Channels; 1993; 1(2):121-34. PubMed ID: 8081716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies.
    Prather PL; Martin NA; Breivogel CS; Childers SR
    Mol Pharmacol; 2000 May; 57(5):1000-10. PubMed ID: 10779385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.
    Romero J; Fernández-Ruiz JJ; Vela G; Ruiz-Gayo M; Fuentes JA; Ramos JA
    Drug Alcohol Depend; 1998 May; 50(3):241-9. PubMed ID: 9649978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
    Facchinetti F; Del Giudice E; Furegato S; Passarotto M; Leon A
    Glia; 2003 Jan; 41(2):161-8. PubMed ID: 12509806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses.
    Meschler JP; Howlett AC
    Pharmacol Biochem Behav; 1999 Mar; 62(3):473-80. PubMed ID: 10080239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of cannabinoid receptors in the avian brain: similarity of rat and chicken cannabinoid1 receptor recognition sites and expression of cannabinoid2 receptor-like immunoreactivity in the embryonic chick brain.
    Fowler CJ; Nilsson O; Andersson M; Disney G; Jacobsson SO; Tiger G
    Pharmacol Toxicol; 2001 Apr; 88(4):213-22. PubMed ID: 11322181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.
    Slipetz DM; O'Neill GP; Favreau L; Dufresne C; Gallant M; Gareau Y; Guay D; Labelle M; Metters KM
    Mol Pharmacol; 1995 Aug; 48(2):352-61. PubMed ID: 7651369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.